PATLY.AIApplication
19238317 · DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
Filed 2025-06-13 · Granted The official file ↗ · Art unit 1613 · Examiner Ernst V Arnold Easy · CPC A61K 47/52 · Cella Therapeutics, LLC · PROCOPIO, CORY, HARGREAVES & SAVITCH LLP
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
5.2 mo
to disposition 11.6 mo
Statutes raised
·
0 actions read